ESC 365 - Lipid management in high cardiovascular risk patients without prior myocardial infarction or stroke - preliminary data from the VESALIUS-REAL global burden study

Back

ESC2025 Premium Access

Lipid management in high cardiovascular risk patients without prior myocardial infarction or stroke - preliminary data from the VESALIUS-REAL global burden study

Session: Improving pharmacotherapy in primary prevention

Topic: Lipid-Lowering Agents

Speaker: Doctor Q. Chan (Greater London, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Queenie Chan

Amgen Ltd, Greater London (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Cardiovascular risks of ibuprofen versus naproxen: a target trial emulation

Speaker: Doctor A. Bech-Drewes (Aarhus, DK)

Lower rate of ischemic events with alirocumab in patients with atherosclerotic cardiovascular disease but without prior acute ischemic events

Speaker: Professor D. Bhatt (New York, US)

Aspirin for the primary prevention of major adverse cardiovascular events in patients with elevated lipoprotein(a): a meta-analysis

Speaker: Doctor P. Lee (Bronx, US)

Efficacy of inclisiran in patients affected by familial hypercholesterolemia: data from CHOLINET Registry

Speaker: Doctor C. Cotticelli (Naples, IT)

Cardiorenal protective therapy for CKD: Real world data from the Hellenic Cardiorenal Morbidity Snapshots (HECMOS)

Speaker: Doctor I. Leontsinis (Athens, GR)

Access the full session

Improving pharmacotherapy in primary prevention

Speakers: Doctor Q. Chan, Doctor A. Bech-Drewes, Professor D. Bhatt, Doctor P. Lee, Doctor C. Cotticelli...

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources